A subscription to JoVE is required to view this content. Sign in or start your free trial.
Enteric glia are becoming increasingly recognized for their roles in intestinal homeostasis and disease processes, including postoperative complications. Equine patients recovering from emergency exploratory laparotomy suffer from a high risk of inflammatory postoperative conditions, highlighting the importance of establishing repeatable equine enteric glial primary cell culture for study.
Inflammatory postoperative conditions of equine colic (acute abdomen) contribute not only to increased client cost, patient discomfort, and hospitalization time, but in many cases, prove to be life-threatening. A unique population of intestinal cells, enteric glia, are increasingly acknowledged for their roles in sensing the gastrointestinal environment and communicating with surrounding cell types. Interactions between enteric glia and intestinal epithelia may prove critical in establishing how equine enteric glia can alter the mucosal barrier to modulate inflammation in health and colic.
To study this interaction, we present a method of establishing primary equine enteric glial cultures from equine jejunum and exposing the cultures to inflammatory conditions known to be present in colic. Primary enteric glial cultures were obtained from adult horses euthanized for reasons unrelated to colic. Intestinal villi and lamina propria were micro-dissected to expose the submucosa. The isolated submucosa underwent enzymatic digestion with collagenase, protease, and bovine serum albumin for 2-3 h. Next, mechanical digestion involving centrifugation, pipetting, and cell strainers (40-100 µm), yielded a pellet used for plating on 0.05 mg/mL poly-L-lysine-coated wells at a concentration of ~400,000 cells/300 µL of media.
Following confluence and first passage, the enteric glial cells were then exposed to equine recombinant IL-1β (0, 10, 25 ng) for 24 h. To model epithelial-glial interactions at the time of colic, medium conditioned by either control or treated enteric glia was added directly to confluent equine jejunal monolayers while measuring transepithelial electrical resistance (TEER) using a dual-electrode EndOhm chamber. These data demonstrate just one of many potential impactful applications of equine enteric glial culture.
Equine colic is the most prevalent medical presenting complaint for emergency consultation1. With up to 17% of those horses requiring surgical correction, efforts to increase postoperative outcomes should be at the forefront of equine medical research2. Currently, postoperative colic patients experience a high risk of several life-threatening disorders including sepsis/endotoxemic shock (12.3% of patients) and postoperative ileus (13.7% of patients)3. Despite progress in treatment for postoperative complications, there continues to be a need for advanced treatments for preventing or treating these....
Equine enteric glial primary cultures were obtained from three horses humanely euthanized with an overdose of a barbiturate for reasons unrelated to this study. The horses selected for the culture studies were adult horses with no current history of gastrointestinal disease.
1. Submucosal equine enteric glial primary culture
Microdissection of equine jejunum to the submucosal layer (Figure 1) with further enzymatic and mechanical digestion, could produce viable cell cultures of equine enteric glia. The cells demonstrated a pleomorphism with a dominance of spindle-shaped cells consistent with the enteric glia of other species (Figure 2A). The cultures were positive for the selective glial marker, glial fibrillary acidic protein (GFAP), with low fibroblast contamination (alpha SMA,
The aim of this study was to develop a repeatable method of primary culture of equine submucosal enteric glia and demonstrate its application to model epithelial-glial interactions at the time of colic. Enteric glia isolation and culture, which is novel in the horse, has proven beneficial in understanding intestinal disease pathways in pig and rodent models and in humans6,7,13,14. Studying this.......
The authors would like to thank the Morris Animal Foundation for their funding of this project.
....Name | Company | Catalog Number | Comments |
1 M HEPES buffer | Gibco | 15630-080 | |
10 mM HEPES | Life Technologies | 15630-106 | |
2 mM GlutaMAX | Life Technologies | 25050-061 | |
4’6-Diaminidino-2-Phenylindol | Invitrogen | D3571 | |
Advanced DMEM/F12 | Life Technologies | 12634-010 | |
Alpha smooth muscle actin antibody | Abcam | 7817 | |
Amphotericin B | Sigma | AA9529 | 4.4 g/mL stock aliquots, final concentration 1.1 µg/mL |
Anti-Antimicotic 1x | Gibco | 15240-096 | |
B27 | Gibco | 12587010 | |
Bovine Serum Albumin | Sigma | AA3311 | |
BSA 50 mg/mL stock solution | Sigma | A3311 | |
CaCL2 | ACROS Organiics | 206791000 | Component of Equine Ringer ‘s Stock 1: combine with other ingredients, then add 100 mL of this stock to a graduated cylinder and dilute to 1L with deionized water. Adjust pH to 7.4 with 5% CO2. Combine with Equine Ringer’s Stock 2 to make complete “Ringer’s Solution”. |
Collagenase | Sigma | 9891 | |
DMEM-F12 media | Thermo Fisher | 11320033 | |
Donkey anti-rabbit IgG Alexa Fluor 594 | Invitrogen | 21207 | |
EVOM EndOhm dual electrode TEER-measuring chamber | World Precision Instruments | EVM-EL-03-01 | |
EVOM Manual for TEER Measurement | World Precision Instruments | EVM-MT-03-01 | |
G5 | Gibco | 17503012 | |
Gentamicin solution | Sigma | G1272 | Final concentration 20 µg/mL |
GFAP antibody | Abcam | 4674 | |
Goat anti-mouse IgG Alexa Fluor 488 | Invitrogen | 28175 | |
IL-1β ELISA | Thermo Fisher | ESIL1B | |
KCl | Thermo Fisher | P330-500 | Component of Equine Ringer’s Stock 1: combine with other ingredients, then add 100 mL of this stock to a graduated cylinder and dilute to 1L with deionized water. Adjust pH to 7.4 with 5% CO2. Combine with Equine Ringer’s Stock 2 to make complete “Ringer’s Solution”. |
L-glutamine solution | Corning | 25-00-Cl | |
Matrigel | BD Bioscience | 354277 | |
MgCl2 | Thermo Fisher | M33-500 | Component of Equine Ringer’s Stock 1: combine with other ingredients, then add 100 mL of this stock to a graduated cylinder and dilute to 1L with deionized water. Adjust pH to 7.4 with 5% CO2. Combine with Equine Ringer’s Stock 2 to make complete “Ringer’s Solution”. |
N2 | Gibco | 17502048 | |
Na2HPO4 | Thermo Fisher | BP332-1 | Component of Equine Ringer’s Stock 2: combine with other ingredients, then add 100 mL of this stock to a graduated cylinder and dilute to 1L with deionized water. Adjust pH to 7.4 with 5% CO2. Combine with Equine Ringer’s Stock 1 to make complete “Ringer’s Solution”. |
NaCl | Thermo Fisher | S271-10 | Component of Equine Ringer’s Stock 1: combine with other ingredients, then add 100 mL of this stock to a graduated cylinder and dilute to 1L with deionized water. Adjust pH to 7.4 with 5% CO2. Combine with Equine Ringer’s Stock 2 to make complete “Ringer’s Solution”. |
NaH2PO4 | Thermo Fisher | BP329-500 | Component of Equine Ringer’s Stock 2: combine with other ingredients, then add 100 mL of this stock to a graduated cylinder and dilute to 1L with deionized water. Adjust pH to 7.4 with 5% CO2. Combine with Equine Ringer’s Stock 1 to make complete “Ringer’s Solution”. |
NaHCO3 | Thermo Fisher | S637-212 | Component of Equine Ringer’s Stock 2: combine with other ingredients, then add 100 mL of this stock to a graduated cylinder and dilute to 1L with deionized water. Adjust pH to 7.4 with 5% CO2. Combine with Equine Ringer’s Stock 1 to make complete “Ringer’s Solution”. |
Pen/Strep solution | Gemini | 400-109 | |
Poly-L-lysine | Sigma | P2636 | 0.5 mg/mL in 1x borate buffer |
Prism software | GraphPad | ||
Protease | Sigma | P4630 | |
Sodium bicarbonate solution | Sigma | S8761 | 7.5% stock solution |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2025 MyJoVE Corporation. All rights reserved